medigraphic.com

2007, Number S1

<< Back Next >>

Arch Cardiol Mex 2007; 77 (S1)

6. Medical and surgical treatment in the pediatric patient with heart failure

Buendía HA, Calderón CJ, Zabal CC, Ramírez MES, Cervantes SJL, Attie CF

Language: Spanish
References: 53
Page: 54-60
PDF size: 79.91 Kb.


Text Extraction

No abstract


REFERENCES

  1. ADAM S: Cardiovascular drugs in children Angiotensin-converting enzyme inhibitors in pediatric patients. Pediatr Cardiol 1990; 11: 199-207.

  2. ALVA-ESPINOZA C, GÓMEZ-VARGAS J, JIMÉNEZ S, QUINTERO L, VISCAÍNO A, ZAMORA C: Insuficiencia cardíaca en el feto, lactante y niño mayor. Rev Mex Cardiol 2000; 11(2): 275-285.

  3. ARTMAN M, GRAHAM TP: Guidelines for vasodilator therapy of congestive heart failure in infants and children. Am Heart J 1987; 113: 994-1005.

  4. BARNES S. SHIELDS B. BONNEY W: The pediatric cardiology pharmacopoeia: 2004 update. Pediatr Cardiol 2004; 25: 623-646.

  5. BARTON P, GARCÍA J, KAUATH A, KITCHEN L, ZORKA A, LINSDAY C, ET AL: Hemodynamic effects of IV milrinone lactate in pediatric patients with septic shock. Chest. 1996; 109: 1302-1312.

  6. BENGUR A, MELIONES J: Cardiogenic shock En: Goldstein B, Zimmerman J, eds New Horizon. The science and practice of acute medicine. Baltimore, Williams & Wilkins. 1998: 139-159.

  7. BERG R, DONNESTEIN R, PADBURY J: Dobutamine infusing in children pharmacokinetics and hemodynamic actions. Crit Care Med 1993; 21: 768-786.

  8. BERMAN W, YABEK SM, DILLON T: Effects of digoxin in infants with congested circulatory state due to a ventricular septal defect. N Engl J Med 1983; 308: 363-366.

  9. BINK-BOELKENS M: Pharmacologic Management of Arrhythmias. Pediatric Cardiol 2000; 21: 508- 515.

  10. BOOKER PD, EVANS C, FRANKS R: Comparison of the hemodynamic effects dopamine in young children undergoing cardiac surgery. Br J Anaesthesiol 1995; 74: 419-423.

  11. BRAUN JP, SCHNEIDER M, KASTRUP M, LIU J: Treatment of acute heart failure in an infant after cardiac surgery using levosimendan. Eur J Cardiothorac Surg 2004; 26: 228-230.

  12. BRAWN W, BARRON D: Management and outcome in hypoplastic left heart syndrome. Current Paediatrics 2004; 14: 26-32.

  13. BUENDÍA A, CALDERÓN-COLMENERO J, PATIÑO E, ZABAL C, ERDMENGER J, RAMIREZ S, GARCÍAMONTES JA, ATTIE F: Secuencia de estudio en el niño con cardiopatía congénita En: Briones Zubiría M, Programa de actualización continua en pediatría. Tomo 1. Academia Mexicana de Pediatría. Intersistemas editores, México 2004: 525-554.

  14. BUENDÍA A, CALDERÓN-COLMENERO J, ZABAL C, ATTIÉ A: Insuficiencia cardiaca en el feto y el recién nacido en RODRIGUEZ WEBER MA, UDAETA E, Neonatología clínica. Ed Interamericana McGraw Hill. 1ª edición. México 2004: 567-585.

  15. BUENDÍA A, ATTIE F, CALDERÓN-COLMENERO J, ZABAL C: Insuficiencia cardiaca en Pediatría. PAC Cardio-2. Ed. Intersistemas. México, DF. 1999; 32-55.

  16. BUNCHMAN TE, LUNCH RE, WOOD EG: Intravenously administered labetalol for treatment of hypertension in children. J Pediatr 1992; 120: 140-144.

  17. CALDERÓN-COLMENERO J, PATIÑO E, ZARCO E: Urgencias cardiológicas en: Mena Brito J: Urgencias. Temas de pediatría. Asociación Mexicana de Pediatría. Interamericana McGraw-Hill. México 1998: 239-250.

  18. CALDERÓN-COLMENERO J: Enfermedad de Kawasaki en Attie F, Zabal C, Buendía A: Cardiología Pediátrica. Diagnóstico y tratamiento. Editorial Médica Panamericana. 1ª Edición, México 1993: 409-413.

  19. CALDERÓN-COLMENERO J, ATTIE F: Enfermedad de Kawasaki En: Tratado de Medicina Interna. Academia Nacional de Medicina. Autor Rivero Serrano O. Editorial Médica Panamericana. México. 1994: 1008-1009.

  20. CALDERÓN-COLMENERO J: Insuficiencia cardiaca en SALAS M, PEÑALOZA JL, ARMAS A, MACÍAS M: Guía para el diagnóstico y terapéutica en Pediatría. México. Ed. Masson Doyma. 2004; 198-206.

  21. CERVANTES JL, CALDERÓN-COLMENERO J, GARCÍAMONTES JA, PATIÑO-BAHENA E, GONZÁLEZ H, SOULE M, RAMÍREZ S: Enfermedad de Kawasaki, conceptos sobre la cirugía de revascularización coronaria en edad pediátrica. Arch Cardiol Méx 2006; 76: 75-79.

  22. CHANG AC, ATZ AM, WERNOUSKY G, BURKE RP, WESSEL DL: Milrinone systemic and pulmonary hemodynamic effects in neonate after cardiac surgery. Anesth Analg. 1998; 86: 283-289.

  23. DEAL B, WOLFF G, GELBAND H: Current concepts in diagnosis and management of arrhytmias in infants and children. 1998. Ed Futura. USA 1998: 309-28.

  24. Digitalis Investigation Group: The effects of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997; 336: 525-533.

  25. DRUCKER NA, COLON SD, LEWIS AB: Gammaglobulin treatment of acute myocarditis in the pediatric population. Circulation 1994; 89: 252-257.

  26. ERANEN M, PERSONEN E, WALLGREN EI: Enalapril in children with congestive heart failure. Acta Paediatr Scand 1991; 80: 555-558.

  27. FERRER PL: Fetal Arrhythmias en DEAL BJ, WOLF GS, GELBAND H. Current’s concepts in diagnosis and management of arrhythmias in infants and children. 1a ed. Editorial Futura Publishing. Armonk, NY. 1998: 17-63.

  28. GARCÍA-MONTES JA, CALDERÓN-COLMENERO J: Farmacología cardiovascular en: QUEVEDO A, MARTÍNEZ Y, DUQUE JI, MEJÍA JA. Fundamentos de pediatría. El niño en estado crítico. 1ª edición. Corporación para investigaciones biológicas. Medellín, Colombia 2001: 229-236.

  29. GERSONY W: Major advances in pediatric cardiology in the 20th century. II. Therapeutics. J Pediatr 2001; 139: 328-333.

  30. HABIB DM, PADBURY JF, ANAS NG, PERKIN RM, MINEGAR C: Dobutamine pharmacokinetics and pharmacodynamics in pediatric intensive care patients. Crit Care Med 1992; 20: 601-608.

  31. HELFAER M, WILSON M, NICHOLS D: Pharmacology of cardiovascular drugs en NICHOLS D, CAMERON D, GREELY W, LAPPE D, UNGERLEIDER R, WETZEL R, eds. Critical heart disease in infants and children. St Louis, Mosby-Year Book. 1995: 185-213.

  32. HERADA K, TAMURA M, ITU T: Effects of low dosis dobutamine on left ventricular diastolic filling in children. Pediatr Cardiol 1996; 17: 220-225.

  33. HOBBINS SM, FOWLER RS, ROWE RD: Spironolactone therapy in infants with congestive heart failure secondary to congenital heart disease. Arch Dis Child 1981; 56: 934-938.

  34. INNES PA, FRAZER RS, BROKER PD, ET AL: Comparison of the haemodynamic effects of dobutamine with enoximone after open heart surgery in small children. Br J Anaesth 1994; 71(1): 77-81.

  35. KAY J, COLAN S, STEVEN D, GRAHAM T: Congestive heart failure in pediatric patients. Am Heart J 2001; 142 (5): 923-928.

  36. KERSTEN JR, MONTGOMERY MW, PAGEL PS, WARLTIER DC: Levosimendan, a new positive inotropic drug, decreases myocardial infarct size via activation of KATP channels. Anesth Analg 2000; 90: 5-11.

  37. KUSHNER HI, BURNS JC, BASTIAN JF, TURNERE CH: The histories of Kawasaki’s disease. Progress in Pediatrics Cardiology 2004; 19: 91-97.

  38. LACTINEN P. HAPPONEN JM, SAINRANEN H, PELTOLA K, RAUTIAINEN P: Amrinone versus dopamine and nitroglicerin in neonate after atrial switch operation for transposition of the great arteries. J Cardiothorac Vasc Anesth. 1999; 13: 186-190.

  39. MURPHY MB, ELLIOT WJ: Dopamine and dopamine receptor agonist in cardiovascular therapy (review). Crit Care Med 1990; 18(suppl 1): S14-S18.

  40. RAMAMMORTHY C, ANDERSON GD, WILLIAM GD, LYNN AM: Pharmacokinetics and side effects of milrinone in infants and children after open heart sugery. Anesth Analg 1998; 86: 283-289.

  41. REDDY M, HANLEY F: Mechanical support of the myocardium En: CHANG A, HANLEY F, WERNOVSKY G, WESSEL D, eds. Pediatric cardiac intensive care. Baltimore, Williams & Wilkins. 1998: 345-374.

  42. RODRÍGUEZ L: Insuficiencia cardíaca en edad pediátrica En: ATTIE F, ZABAL C, BUENDÍA A: Cardiología Pediátrica. Diagnóstico y tratamiento. Editorial Médica Panamericana. 1ª Edición México. 1993: 454-460.

  43. ROSSI A: Cardiac diagnostic evaluation En: CHANG A, HANLEY F, WERNOVSKY G, WESSEL D, eds. Pediatric cardiac intensive care. Baltimore, Williams & Wilkins. 1998: 37-51.

  44. SACHETTI A, MOYER V, BARICELLA R: Primary cardiac arrhythmias in children. Pediatric Emergency Care 1999; 15(2): 95-98.

  45. SCHMIDT KG, ULMER HE, SILVERMAN NH: Perinatal outcome of fetal complete atrioventricular block: a multicenter experience. J Am Coll Cardiol 1991; 17: 1360-1366.

  46. SHEKERDEMIAN L, REDINGTON A: Cardiovascular pharmacology En: CHANG A, HANLEY F, WERNOVSKY G, WESSEL D, eds. Pediatric cardiac intensive care. Baltimore, Williams & Wilkins. 1998: 45-72.

  47. SHADDY RE, TONI LY, GIDDING SS: Beta-blocker treatment of dilated cardiomyopathy with congestive heart failure in children: a multiinstitutional experience. J Heart Lung Transplant 1999; 18: 269-274.

  48. SHADDY RE, TEITEL DF, BRET C: Short-term hemodynamic effects of captopril in infants with congestive heart failure. Arch Pediatr Adolesc Med 1988; 142: 100-105.

  49. SHOW NJ, WILSON N, DICKINSON DF: Captopril in heart failure secondary to a left to right shunt. Arch Dis Child 1988; 63: 360-3.

  50. TOBIN J, WETZEL R: Cardiovascular physiology and shock En: NICHOLS D, CAMERON D, GREELY W, LAPPE D, UNGERLEIDER R, WETZEL R. Critical heart disease in infants and children. St Louis, Mosby-Year Book. 1995: 17-63.

  51. WALKER K: Myocardial assist device en NICHOLS D, CAMERON D, GREELY W, LAPPE D, UNGERLEIDER R, WETZEL R, eds. Critical heart disease in infants and children. St Louis, Mosby-Year Book. 1995: 531-584.

  52. WEBSTER NW, NEUTZE JM, CALDER AL: Acute hemodynamic effects of converting enzyme inhibition in children with intracardiac shunts. Pediatr Cardiol 1992; 13(3): 129-135.

  53. VAN ENGELEN AD, WEITJENS O, BRENNER JI: Management outcome and follow-up of fetal tachycardia. J Am Coll Cardiol 1994; 24: 1371-1375.




2020     |     www.medigraphic.com